Yantai Zhenghai Bio-Tech Co Ltd (300653) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.035x

Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥30.47 Million ≈ $4.46 Million USD) by net assets (CN¥874.47 Million ≈ $127.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300653 stock market capitalisation for the company's overall valuation and market capitalisation.

Yantai Zhenghai Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yantai Zhenghai Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yantai Zhenghai Bio-Tech Co Ltd ranked by their cash flow conversion efficiency. Explore Yantai Zhenghai Bio-Tech Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Shandong Xinjufeng Technology Packaging Co. Ltd. A
SHE:301296
N/A
Bumble Inc
NASDAQ:BMBL
0.087x
ASTON MART.LA.UADR LS-001
F:A5S0
0.262x
Guangdong Liantai Environmental Protection Co Ltd
SHG:603797
0.040x
Guangdong Dcenti Auto-Parts Stock Ltd Co
SHG:603335
0.088x
Mercurity Fintech Holding Inc ADR
NASDAQ:MFH
-0.118x
Ciwen Media Co Ltd
SHE:002343
-0.057x
Electra Co Pr
TA:ECP
0.041x

Annual Cash Flow Conversion Efficiency for Yantai Zhenghai Bio-Tech Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2025. View 300653 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥889.48 Million
≈ $130.16 Million
CN¥97.19 Million
≈ $14.22 Million
0.109x -35.85%
2024-12-31 CN¥888.78 Million
≈ $130.06 Million
CN¥151.38 Million
≈ $22.15 Million
0.170x -10.53%
2023-12-31 CN¥948.07 Million
≈ $138.73 Million
CN¥180.48 Million
≈ $26.41 Million
0.190x -12.33%
2022-12-31 CN¥865.11 Million
≈ $126.59 Million
CN¥187.84 Million
≈ $27.49 Million
0.217x +2.63%
2021-12-31 CN¥785.27 Million
≈ $114.91 Million
CN¥166.13 Million
≈ $24.31 Million
0.212x +15.53%
2020-12-31 CN¥646.72 Million
≈ $94.64 Million
CN¥118.43 Million
≈ $17.33 Million
0.183x +4.13%
2019-12-31 CN¥588.38 Million
≈ $86.10 Million
CN¥103.48 Million
≈ $15.14 Million
0.176x +20.10%
2018-12-31 CN¥529.00 Million
≈ $77.41 Million
CN¥77.47 Million
≈ $11.34 Million
0.146x +8.07%
2017-12-31 CN¥483.18 Million
≈ $70.70 Million
CN¥65.47 Million
≈ $9.58 Million
0.136x -37.22%
2016-12-31 CN¥228.16 Million
≈ $33.39 Million
CN¥49.25 Million
≈ $7.21 Million
0.216x -15.34%
2015-12-31 CN¥179.40 Million
≈ $26.25 Million
CN¥45.74 Million
≈ $6.69 Million
0.255x -47.32%
2014-12-31 CN¥63.62 Million
≈ $9.31 Million
CN¥30.79 Million
≈ $4.51 Million
0.484x -58.71%
2013-12-31 CN¥29.34 Million
≈ $4.29 Million
CN¥34.38 Million
≈ $5.03 Million
1.172x +133.32%
2012-12-31 CN¥-6.43 Million
≈ $-941.02K
CN¥22.62 Million
≈ $3.31 Million
-3.517x --

About Yantai Zhenghai Bio-Tech Co Ltd

SHE:300653 China Biotechnology
Market Cap
$390.35 Million
CN¥2.67 Billion CNY
Market Cap Rank
#13635 Global
#4077 in China
Share Price
CN¥14.82
Change (1 day)
+1.65%
52-Week Range
CN¥13.54 - CN¥22.55
All Time High
CN¥53.33
About

Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral restoration membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etching agent, dental pit and fissure sealant, active biol… Read more